According to the World Health Organization (WHO), it is estimated that each year
approximately 11 million people suffer from burn wounds, 180,000 of whom die because of …

Ketamine was introduced commercially in 1970 with the manufacturer's description as a
“rapidly acting, nonbarbiturate general anesthetic” and a suggestion that it would be useful …

Summary S (+)-ketamine, the pure dextrorotatory enantiomer of ketamine has been
available for clinical use in analgesia and anesthesia for more than 25 years. The main …

We compared ketamine–xylazine (K, 100 mg/kg; X, 10 mg/kg) and ketamine–
dexmedetomidine (K, 75 mg/kg; D, 1.0 mg/kg) for their ability to produce anesthesia, their …

Most of the paediatric published studies concerning dexmedetomidine are observational in
nature, with limited control groups or comparators. Adverse effects (eg bradycardia) still …

Objective Ketamine is an anaesthetic agent with a unique dissociative profile and
pharmacological effects ranging from the induction and maintenance of anaesthesia to …

BACKGROUND AND OBJECTIVES: Despite advances, inappropriate analgesic treatment
for burn patients is still seen. The objective of this review was to collect data on pain …

Introduction Optimal management of sedation, analgesia and delirium offers comfort and
security for the critical care patient, allows support measures to be applied more easily and …

Introducción El óptimo manejo de la sedación, analgesia y delirium ofrece al paciente crítico
comodidad y seguridad, facilita el buen desarrollo de medidas de soporte y manejo integral …

Ketamine is considered as a promising drug for many clinical applications even after five
decades since its discovery. Ketamine is a dissociative anesthetic agent with a variety of …